Despite efficacy, most patients discontinued therapyJuly 2, 2012AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
New antibody achieves high CR rate in relapsed/refractory adult ALLJune 14, 2012Leukemia, Myelodysplasia, Transplantation
CD19-redirected T cells induce remission in CLL patientsAugust 10, 2011Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
ODAC votes against one leukemia, one NHL drugMarch 23, 2010Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Fostamatinib successfully targets the B-cell receptorDecember 13, 2009Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Ofatumumab receives accelerated approval from FDAOctober 27, 2009Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Survival improves for AYAs with leukemia and lymphomaAugust 25, 2009Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Overcoming limitations of haploidentical HSCTMay 18, 2009Leukemia, Myelodysplasia, TransplantationTransplantation
Study shows imatinib response is durable and improves with timeDecember 22, 2008Leukemia, Myelodysplasia, Transplantation
